Lineage Cell Therapeutics Inc. (NYSE:LCTX) is one of the 10 best penny stocks that could triple your money. On March 24, ...
Four apps from the new Celonis Platform Apps Program enable companies to increase performance, cut downtime, reduce cycle times, and drive value across Banking, Oil & Gas and Chemical, Manufacturing, ...
CHICAGO--(BUSINESS WIRE)--Reveal, the global provider of the leading AI-powered eDiscovery, review and investigations platform, is thrilled to announce the official kick-off of an expanded partner ...
Cybersecurity company Barracuda Networks Inc. today announced an expansion to its BarracudaONE cybersecurity platform and an ...
"The introduction of the MSP program and those services-based SKUs is any MSP's dream," one Extreme Networks' partner told CRN of the company's first MSP program. Extreme Networks is launching its ...
Design, a national leader in instructional design and online program development, today announced that The Essentials: Core Competencies for Professional Nursing Education, the definitive competency ...
NEW YORK, May 24, 2023 /PRNewswire/ -- Launch Underwriters, an innovative program administrator platform, has officially entered the insurance program space, positioned to attract best-in-class ...
The unwind rarely behaves like a discrete migration project. It behaves like a multi-quarter diversion of attention and ...
RESTON, Va., Oct. 7, 2025 /PRNewswire/ -- ICF (NASDAQ:ICFI), a leading global solutions and technology provider, announced the next generation of Sightline®, its industry-leading utility program ...
No-Headquarters/BOZEMAN, Mont.--(BUSINESS WIRE)--Snowflake (NYSE: SNOW), the AI Data Cloud company, today announced the launch of its One Million Minds + One Platform program with the goal of training ...
New program gives industry leaders access to foundational sensing platform shaping the next generation of spatial intelligence and Physical AI applications LONDON ...
Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results